Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674736011 | Mesalazine 250 mg rectal suppository | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3674738012 | Mesalamine 250 mg rectal suppository | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3674739016 | Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
66627601000001115 | Mesalazine 250mg suppositories | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Is a | Product containing mesalazine in rectal dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has active ingredient | Mesalazine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Rectal dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Conventional release rectal suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has presentation strength numerator value | 250 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has presentation strength denominator unit | Suppository | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has basis of strength substance | Mesalazine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has unit of presentation | Suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has precise active ingredient | Mesalazine | true | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Is a | Product containing only mesalazine in rectal dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Conventional release rectal suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has unit of presentation | Suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | suppository.rectal ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Rectal route | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Rectal dose form | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Is a | Mesalazine | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Conventional release rectal suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has unit of presentation | Suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has active ingredient | Mesalazine | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Conventional release rectal suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has unit of presentation | Suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has specific active ingredient | Mesalazine | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has dispensed dose form | Suppository | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Has manufactured dose form | Suppository | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | VMP non-availability indicator | Not available | true | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Mesalazine 250mg suppository - product | Is a | False | Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Inferred relationship | Existential restriction modifier | |
Asacol 250mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd) | Is a | True | Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Inferred relationship | Existential restriction modifier | |
Mesalazine 250mg suppositories 20 suppository | Is pack of | False | Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Inferred relationship | Existential restriction modifier | |
Mesalazine 250mg suppositories 20 suppository | Has VMP | True | Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Inferred relationship | Existential restriction modifier | |
Mesalazine 250mg suppositories (Ennogen Healthcare Ltd) | Is a | False | Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Inferred relationship | Existential restriction modifier | |
Mesalazine 250mg suppositories (Colorama Pharmaceuticals Ltd) | Is a | False | Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Inferred relationship | Existential restriction modifier | |
Mesalazine 250mg suppositories (J M McGill Ltd) | Is a | False | Product containing precisely mesalazine 250 milligram/1 each conventional release rectal suppository | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets